PRECIGEN, INC.

For the period ended Dec 31, 2025. Filed Mar 25, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 25, 2026

PGEN$4.52-4.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations for the Years Ended , and

(Amounts in thousands, except share and per share data)	2025	2024	2023
Revenues
Collaboration and licensing revenues	$1,818	$—	$75
Product revenues, net	3,975	422	840
Service revenues	3,891	3,503	5,310
Total revenues	9,684	3,925	6,225
Operating Expenses
Cost of products and services	4,823	4,267	6,119
Research and development	41,333	53,070	48,614
Selling, general and administrative	70,128	41,293	40,415
Impairment of goodwill	3,907	7,409	10,390
Impairment of other noncurrent assets	—	32,915	445
Total operating expenses	120,191	138,954	105,983
Operating loss	(110,507)	(135,029)	(99,758)
Other Income (Expense), Net
Change in fair value of warrant liabilities	(139,523)	—	—
Interest expense	(3,867)	(6)	(468)
Interest income	3,215	1,418	3,237
Other income, net	43	5,589	627
Total other (expense) income, net	(140,132)	7,001	3,396
Loss before income taxes	(250,639)	(128,028)	(96,362)
Income tax (expense) benefit	(3)	1,793	458
Net loss	$(250,642)	$(126,235)	$(95,904)
Deemed dividend on preferred stock	(179,000)	—	—
Net loss attributable to common shareholders	$(429,642)	$(126,235)	$(95,904)
Net loss per share attributable to common shareholders
Net loss per share attributable to common shareholders, basic and diluted	$(1.37)	$(0.47)	$(0.39)
Weighted average shares outstanding, basic and diluted	312,980,562	267,727,426	244,536,221

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.